Minnesota Healthcare
Compliance Guide

Minnesota presents a moderately complex but generally favorable regulatory environment for healthcare companies, particularly those leveraging telehealth. The state has proactively adapted its laws to support virtual care, recognizing its potential to expand access, especially in rural areas. Key regulatory bodies include the Minnesota Board of Medical Practice, the Minnesota Board of Pharmacy, and the Minnesota Department of Health, all of which play crucial roles in licensing, oversight, and enforcement. The state has embraced a balanced approach, seeking to integrate telehealth into the existing healthcare framework while maintaining patient safety and quality of care standards. Recent legislative actions have focused on solidifying telehealth parity, expanding reimbursement, and clarifying professional practice standards. Minnesota's healthcare market is robust, with a strong emphasis on integrated systems and community health. For companies looking to enter or expand, understanding the nuances of its Corporate Practice of Medicine (CPOM) doctrine, specific telehealth requirements, and evolving prescribing rules is paramount. While not as restrictive as some CPOM states, Minnesota maintains clear distinctions between professional and commercial entities. The state's commitment to expanding access to care, coupled with its relatively clear regulatory framework for telehealth, makes it an attractive market, provided companies navigate its specific compliance requirements diligently. The general business climate is supportive of innovation, but strict adherence to professional licensure, scope of practice, and patient protection laws is rigorously enforced. Companies must be prepared for thorough regulatory scrutiny, particularly concerning patient-provider relationships, prescribing practices, and ownership structures.

Minnesota maintains a Corporate Practice of Medicine (CPOM) doctrine, though it is primarily derived from statutory interpretation and regulatory enforcement rather than explicit common law prohibition. The underlying principle is that medical decisions and the practice of medicine should remain free from commercial influence or control by non-licensed entities. Minnesota Statutes § 147.081, Subd. 1, states that 'No person shall practice medicine in this state unless the person is licensed by the board.' This, combined with the prohibition on fee-splitting (Minn. Stat. § 147.091, Subd. 1(r)), forms the basis of CPOM enforcement. The Minnesota Board of Medical Practice (MBMP) interprets these statutes to mean that corporations or other entities not owned and controlled by licensed physicians cannot employ physicians to provide medical services or otherwise interfere with a physician's independent medical judgment. As such, non-physicians generally cannot own entities that directly provide medical services. Professional entities, such as Professional Corporations (PC) or Professional Limited Liability Companies (PLLC), must be owned by licensed professionals. For medical practices, this typically means ownership by physicians licensed in Minnesota. This directly impacts telehealth companies, medspas, dental practices, and wellness clinics. A non-physician-owned entity cannot directly employ physicians, nurse practitioners, or physician assistants to deliver medical care. Instead, a common compliant structure involves a 'PC-MSO' model, where a physician-owned professional entity (PC) provides the clinical services, and a separate, non-physician-owned Management Services Organization (MSO) provides administrative, non-clinical support services under a Management Services Agreement (MSA). The MSA must be carefully drafted to ensure the MSO does not exert control over clinical decision-making, physician employment, or patient care. Fee-splitting is strictly prohibited, meaning the MSO's compensation must be for legitimate management services at fair market value and not tied to a percentage of professional fees. Dental practices are subject to similar restrictions under Minn. Stat. § 150A.05, Subd. 1. Medspas and wellness clinics offering medical services (e.g., injectables, IV therapy, laser treatments) must ensure the medical component is delivered by a physician-owned entity or directly by a physician, with proper supervision of delegated tasks. Non-physician ownership of the entity providing medical services is generally not permitted, necessitating careful structuring to separate the professional and administrative functions.

Minnesota has a robust framework for telehealth, largely codified in Minnesota Statutes § 62A.671 to § 62A.676, which defines and regulates telehealth services. The state explicitly permits the establishment of a provider-patient relationship via telehealth, provided that the standard of care is met and the service is clinically appropriate. The law requires that telehealth services be delivered by a healthcare provider acting within their scope of practice and licensed to practice in Minnesota. All modalities are generally permitted: live interactive audio and video are explicitly recognized, and audio-only telehealth is permitted when clinically appropriate and when the patient has an established relationship with the provider or practice, or under specific circumstances defined by the Department of Human Services. Asynchronous (store-and-forward) technology is also allowed. There are no specific telehealth registration requirements for providers beyond their standard professional licensure in Minnesota. However, providers must ensure they are licensed by their respective Minnesota licensing board (e.g., Board of Medical Practice, Board of Nursing). Informed consent is a critical component of Minnesota's telehealth regulations. Before providing telehealth services, a healthcare provider must obtain informed consent from the patient, which includes informing the patient about the nature of telehealth, the potential risks and benefits, and the patient's right to refuse telehealth services and receive in-person care. This consent must be documented. There are generally no geographic restrictions within Minnesota for telehealth services; providers can treat patients located anywhere within the state, provided they meet all other regulatory requirements. Out-of-state providers must be licensed in Minnesota to treat Minnesota patients via telehealth, unless an exception applies (e.g., specific interstate compacts or emergency situations). The Minnesota Department of Human Services (DHS) has also issued guidance on telehealth for state-regulated programs, further clarifying reimbursement and service delivery standards.

Minnesota's prescribing rules for telehealth largely align with in-person prescribing standards, with specific considerations for controlled substances. For non-controlled substances, providers licensed in Minnesota can prescribe via telehealth after establishing a legitimate patient-provider relationship and conducting an appropriate evaluation, consistent with the standard of care. For controlled substances, Minnesota Statutes § 152.12, Subd. 1, requires a legitimate medical purpose and a practitioner acting in the usual course of professional practice. The federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation for prescribing controlled substances via the internet, with certain exceptions. During and post-COVID-19 Public Health Emergency (PHE), federal waivers allowed for the prescribing of Schedule II-V controlled substances without an initial in-person visit via telehealth. However, the future of these federal waivers is subject to DEA rulemaking. As of late 2024/early 2025, the DEA has proposed new rules that would largely reinstate the in-person requirement for Schedule II-V controlled substances, with a 30-day supply exception for an initial telehealth prescription before an in-person visit is required. Providers must monitor federal DEA guidance closely. Minnesota law, specifically Minn. Stat. § 152.11, Subd. 1a, mandates that prescribers check the Minnesota Prescription Monitoring Program (PMP) before prescribing a Schedule II, III, IV, or V controlled substance to a patient, with certain exceptions (e.g., hospice care, direct administration). This PMP check is required for both initial prescriptions and at least annually for ongoing controlled substance prescriptions. There are no specific quantity or refill limitations via telehealth beyond those applicable to in-person prescribing, which are generally based on clinical appropriateness and standard of care. However, providers should exercise caution and document thoroughly when prescribing controlled substances, particularly for long-term management. For specific drug classes like GLP-1s, testosterone, and stimulants, providers must adhere to all standard prescribing guidelines, including proper diagnosis, patient monitoring, and adherence to specific clinical protocols. For example, stimulants for ADHD often require comprehensive initial evaluations and ongoing monitoring, which can be facilitated by telehealth but must meet the same rigor as in-person care. Testosterone therapy requires careful assessment of indications and monitoring of hormone levels. All prescribing must be within the prescriber's scope of practice and adhere to the ethical guidelines set by their respective licensing board.

Minnesota's scope of practice for mid-level providers is generally progressive, granting significant autonomy to Nurse Practitioners (NPs) and Physician Assistants (PAs), though with distinct regulatory frameworks. Nurse Practitioners (NPs): Minnesota grants full practice authority to NPs, meaning they can practice independently without physician supervision or collaborative practice agreements, provided they meet specific educational and certification requirements. Minn. Stat. § 148.235, Subd. 1, defines 'Advanced practice registered nurse' (APRN) and includes nurse practitioners. Subd. 4 outlines the scope of practice, which includes diagnosing, prescribing, and managing patient care. While NPs can practice independently, many choose to work within collaborative teams. This full practice authority significantly streamlines operations for telehealth companies and other healthcare businesses, as it reduces the administrative burden of securing and maintaining physician supervision agreements. Physician Assistants (PAs): PAs in Minnesota operate under a 'delegated practice' model, but with considerable autonomy. While PAs are generally required to have a 'supervising physician' (Minn. Stat. § 147A.09), the level of supervision is often indirect and focused on general oversight rather than direct, real-time involvement in every patient encounter. The supervising physician is responsible for the overall medical care provided by the PA, but the PA is authorized to perform medical services delegated by the supervising physician, within the PA's education, training, and experience. The Minnesota Board of Medical Practice regulates PA practice and requires a 'delegation agreement' outlining the scope of services the PA is authorized to perform. This agreement does not need to be submitted to the Board but must be readily available. For medspas and other clinics, PAs can perform a wide range of procedures under appropriate delegation. Medical Assistants (MAs): The scope of practice for Medical Assistants is generally limited to administrative and clinical tasks that do not require independent medical judgment. In medspas, MAs can perform tasks like preparing patients, assisting with procedures, and providing post-procedure instructions, but they cannot independently perform invasive procedures, administer injectables, or make clinical assessments. Any delegated tasks must be within the MA's training and competence and performed under the direct supervision of a licensed physician, NP, or PA. Delegation Rules: Delegation of tasks must always be within the delegating practitioner's scope of practice and the delegatee's training and competence. The delegating practitioner retains ultimate responsibility for patient care. For telehealth, these principles apply equally; a practitioner must ensure proper oversight and delegation regardless of the modality of service delivery.

Navigating Minnesota's Corporate Practice of Medicine (CPOM) doctrine necessitates careful business structuring, often leading to the adoption of a Professional Corporation (PC) and Management Services Organization (MSO) model. PC-MSO Structure: This model is typically required when non-physician investors or entities wish to participate in the financial success of a healthcare business without violating CPOM. The Professional Corporation (PC) or Professional Limited Liability Company (PLLC) is owned by Minnesota-licensed physicians (or other licensed professionals, e.g., dentists for dental practices, NPs for certain independent practices) and directly employs the clinical providers (physicians, NPs, PAs). This PC delivers all professional medical services. A separate Management Services Organization (MSO), which can be owned by non-physicians, provides all non-clinical, administrative, and management services to the PC. These services include billing, scheduling, marketing, IT, human resources for administrative staff, and facilities management. Fee-Splitting Rules: Minnesota Statutes § 147.091, Subd. 1(r) prohibits fee-splitting, stating that a physician cannot 'divide fees with, or promise to pay a part of a fee to, any other physician or person in consideration of the referral of a patient.' This is a critical consideration for PC-MSO structures. The MSO's compensation from the PC must be for legitimate management services provided at fair market value (FMV) and should not be directly tied to a percentage of the professional fees generated by the PC. Instead, MSO fees are typically structured as a fixed fee, a cost-plus model, or a percentage of gross collections that can be justified as FMV for the services rendered, provided it does not create an inducement for referrals or control clinical judgment. Management Services Agreement (MSA) Requirements: The MSA between the PC and MSO must clearly delineate the responsibilities of each entity, ensuring that the MSO has no control over clinical decision-making, physician hiring/firing (for clinical roles), or patient care protocols. The PC must maintain sole authority over all medical aspects of the practice. The MSA should specify the services provided by the MSO, the compensation structure, term, termination clauses, and intellectual property ownership. Professional Corporation Requirements: To form a PC or PLLC in Minnesota, the entity must be organized under Minnesota Statutes Chapter 319B (Professional Firms Act). The owners and officers providing professional services must be licensed in Minnesota for the profession for which the PC is organized. For a medical PC, all shareholders must be licensed physicians. This ensures that the entity providing medical services is professionally owned and controlled. Structuring Ownership for Compliance: For telehealth companies, medspas, and other clinics, this means the clinical entity must be physician-owned (or owned by other appropriate licensed professionals). Non-clinical functions can be housed in a separate, non-physician-owned MSO. Careful legal counsel is essential to ensure that all agreements (MSA, employment agreements, leases) comply with Minnesota's CPOM and anti-kickback statutes, and that the MSO's services and compensation are at FMV and do not constitute illegal fee-splitting or undue influence over clinical practice.

Minnesota's regulatory landscape for healthcare continues to evolve, with several key developments and ongoing legislative discussions impacting telehealth, CPOM, and prescribing. In 2023, Minnesota enacted significant legislation (HF 2930 / SF 2995) aimed at solidifying telehealth access and reimbursement parity. This legislation, effective January 1, 2024, made permanent many of the telehealth flexibilities introduced during the COVID-19 PHE. It mandates that commercial health plans and Medical Assistance (Medicaid) reimburse for telehealth services at rates equivalent to in-person services for certain providers and services, fostering long-term stability for telehealth companies. It also expanded the definition of telehealth to include audio-only services under specific conditions, particularly for established patient relationships, and clarified informed consent requirements. Regarding CPOM, while there haven't been explicit legislative changes to the underlying statutes, the Minnesota Board of Medical Practice (MBMP) continues its vigilant enforcement. Recent Board actions and advisory opinions consistently reinforce the prohibition against non-licensed individuals or entities interfering with medical judgment or engaging in fee-splitting. Companies should monitor MBMP disciplinary actions for insights into specific areas of enforcement focus, such as improper delegation in medspas or MSO arrangements that cross into clinical control. On the prescribing front, the most significant developments are at the federal level concerning the future of the Ryan Haight Act waivers for controlled substance prescribing via telehealth. While Minnesota's PMP check requirements remain steadfast, the DEA's proposed rules (expected to be finalized in 2024-2025) will dictate the necessity of an in-person visit for initial controlled substance prescriptions. This will directly impact telehealth companies prescribing Schedule II-V drugs. Minnesota is an active participant in several interstate compacts. The state joined the Interstate Medical Licensure Compact (IMLC) in 2015, allowing eligible physicians to obtain licenses in multiple compact states more efficiently. It also participates in the Nurse Licensure Compact (NLC), facilitating multi-state practice for nurses. These compacts significantly reduce licensing barriers for telehealth providers looking to expand into Minnesota. Future legislation is likely to focus on refining reimbursement models, addressing potential fraud and abuse in telehealth, and potentially expanding compact participation for other professions.

For healthcare companies entering or expanding into Minnesota, a methodical approach to compliance is essential. Step-by-Step Compliance Checklist: 1. Entity Formation: Establish a Minnesota Professional Corporation (PC) or Professional Limited Liability Company (PLLC) for clinical services, ensuring all owners are licensed Minnesota professionals. Simultaneously, form a separate Management Services Organization (MSO) for administrative functions. 2. Licensure: Ensure all clinical providers (physicians, NPs, PAs) are individually licensed by their respective Minnesota licensing boards. Verify compact eligibility where applicable (IMLC, NLC). 3. Management Services Agreement (MSA): Draft a comprehensive MSA between the PC and MSO, clearly delineating responsibilities, ensuring MSO compensation is at Fair Market Value (FMV) and does not constitute fee-splitting, and explicitly stating the MSO has no control over clinical decisions. 4. Policies & Procedures: Develop robust P&Ps for telehealth service delivery, including patient intake, informed consent, privacy (HIPAA), data security, emergency protocols, and continuity of care. 5. Prescribing Protocols: Implement strict prescribing protocols, especially for controlled substances, including mandatory PMP checks, adherence to federal Ryan Haight Act requirements (current and future), and documentation standards. 6. Scope of Practice Adherence: Ensure all providers operate strictly within their Minnesota-defined scope of practice. For PAs, develop and maintain a clear delegation agreement. For MAs, ensure direct supervision for delegated tasks. 7. Informed Consent: Implement a clear process for obtaining and documenting informed consent for telehealth services, as required by Minn. Stat. § 62A.673. Common Pitfalls to Avoid: 1. Undercapitalized PC: Ensure the PC is adequately capitalized and has sufficient resources to operate independently of the MSO, demonstrating true separation. 2. Improper MSO Compensation: Avoid percentage-based MSO fees that could be construed as illegal fee-splitting or excessive. 3. Clinical Control by MSO: Do not allow the MSO to dictate clinical protocols, hire/fire clinical staff, or influence medical judgment. 4. Unlicensed Practice: Do not allow non-licensed individuals to perform tasks requiring a license, or allow out-of-state providers to treat Minnesota patients without proper licensure. 5. Insufficient Documentation: Maintain meticulous records for all patient encounters, informed consents, and prescribing decisions. Timeline Expectations: Licensing for individual providers can take several weeks to a few months, depending on the board and completeness of the application. Entity formation and drafting of complex agreements like MSAs can take 1-3 months. Overall, expect a 3-6 month timeline for full regulatory setup before commencing operations. Early engagement with experienced legal counsel specializing in Minnesota healthcare law is crucial.